A simple approach for analyzing longitudinally measured biomarkers is to calculate summary measures such as the area under the curve (AUC) for each individual and then compare the mean AUC between treatment groups using methods such as t test. This two-step approach is difficult to implement when there are missing data since the AUC cannot be directly calculated for individuals with missing measurements. Simple methods for dealing with missing data include the complete case analysis and imputation. A recent study showed that the estimated mean AUC difference between treatment groups based on the linear mixed model (LMM), rather than on individually calculated AUCs by simple imputation, has negligible bias under random missing assumptions an...
The area under the ROC curve (AUC) and the Youden index are standard measures of biomarkers\u27 accu...
Joint analysis of self-report and biomarker measurements provides new opportunities to understand an...
Ye et al. (2008) proposed a joint model for longitudinal measurements and time-to-event data in whic...
In a longitudinal study of biomarker data collected during a hospital stay, observations may be miss...
With most clinical trials, missing data presents a statistical problem in evaluating a treatment\u27...
Treatment effects are often evaluated by comparing change over time in outcome measures. However, va...
Sample size determination plays an important role in clinical trials. In the early stage of a design...
The classical method to determine the cut off value between normal and disease group is to calculate...
As a cost effective diagnostic tool, numerous candidate biomarkers have been emerged for different d...
In observational cohort studies, there is frequently interest in modeling longitudinal change in a b...
Many medical studies collect biomarker data to gain insight into the biological mechanisms underlyin...
This paperback edition is a reprint of the 2000 edition. This book provides a comprehensive treatmen...
Previous research suggests that a specific biomarker measured in the blood correlates with cancer st...
Abstract: Longitudinal data are very common in biomedical and clinical research, for example, CD4+ c...
We consider estimation of mixed-effects logistic regression models for longitudinal data when missin...
The area under the ROC curve (AUC) and the Youden index are standard measures of biomarkers\u27 accu...
Joint analysis of self-report and biomarker measurements provides new opportunities to understand an...
Ye et al. (2008) proposed a joint model for longitudinal measurements and time-to-event data in whic...
In a longitudinal study of biomarker data collected during a hospital stay, observations may be miss...
With most clinical trials, missing data presents a statistical problem in evaluating a treatment\u27...
Treatment effects are often evaluated by comparing change over time in outcome measures. However, va...
Sample size determination plays an important role in clinical trials. In the early stage of a design...
The classical method to determine the cut off value between normal and disease group is to calculate...
As a cost effective diagnostic tool, numerous candidate biomarkers have been emerged for different d...
In observational cohort studies, there is frequently interest in modeling longitudinal change in a b...
Many medical studies collect biomarker data to gain insight into the biological mechanisms underlyin...
This paperback edition is a reprint of the 2000 edition. This book provides a comprehensive treatmen...
Previous research suggests that a specific biomarker measured in the blood correlates with cancer st...
Abstract: Longitudinal data are very common in biomedical and clinical research, for example, CD4+ c...
We consider estimation of mixed-effects logistic regression models for longitudinal data when missin...
The area under the ROC curve (AUC) and the Youden index are standard measures of biomarkers\u27 accu...
Joint analysis of self-report and biomarker measurements provides new opportunities to understand an...
Ye et al. (2008) proposed a joint model for longitudinal measurements and time-to-event data in whic...